The trial obtained each its Key endpoints, with semaglutide 2.four mg demonstrating statistically major and exceptional enhancements in liver fibrosis without worsening of steatohepatitis, together with resolution of steatohepatitis without worsening of liver fibrosis in individuals with MASH when compared with placebo.oneMaintain all appointments … Read More